Botulinum toxin type A for facial rejuvenation - United States and United Kingdom perspectives

被引:50
|
作者
Lowe, NJ
机构
[1] Cranley Clin, London W1M 9AD, England
[2] Univ Calif Los Angeles, Sch Med, Dept Dermatol, Los Angeles, CA USA
[3] UCL, Sch Med, Dept Dermatol, London W1N 8AA, England
关键词
D O I
10.1111/j.1524-4725.1998.tb04100.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Botulinum A toxin has been well documented as a successful treatment for hyperfunctional upper facial expression lines. Currently, there are two commercial sources for botulinum toxin-Botox(R) and Dysport(R). Only Boton: is currently available in the United States; however, both Botox(R) and Dysport(R) are available in a number of European and other countries. OBJECTIVES. There are several differences between these two sources of botulinum toxin, including different potency of their dosage units. This article will review the uses of these two sources of botulinum toxin and discuss the dilution and dosing of botulinum toxin for facial expression lines. RESULTS. One unit of Botox(R) is approximately equivalent in potency to 4 LT of Dysport(R). CONCLUSIONS. Both commercial types of botulinum toxin can be used interchangeably with appropriate dosage selection. (C) 1998 by the American Society for Dermatologic Surgery, Inc.
引用
收藏
页码:1216 / 1218
页数:3
相关论文
共 50 条
  • [21] The clinical effect of frontotemporal rhytidectomy combined with botulinum toxin type A injection facial rejuvenation treatment
    Li-na ZHAO
    Meng-tong GONG
    Xiao-feng LIU
    Song-mei XIE
    Tong-kui ZHOU
    [J]. Chinese Journal of Plastic and Reconstructive Surgery, 2019, 1 (03) : 35 - 38
  • [23] Religion in Public Institutions: Comparative Perspectives from the United States, the United Kingdom, and Europe
    Cadge, Wendy
    Griera, Mar
    Lucken, Kristen
    Michalowski, Ines
    [J]. JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION, 2017, 56 (02) : 226 - 233
  • [24] Developing carbon dioxide removal policy and anticipatory perspectives in the United Kingdom and United States
    Harvey, Victoria
    Workman, Mark
    Heap, Richard
    [J]. ENERGY RESEARCH & SOCIAL SCIENCE, 2023, 102
  • [25] Botulinum toxin type A for facial wrinkles
    Camargo, Cristina Pires
    Xia, Jun
    Costa, Caroline S.
    Gemperli, Rolf
    Tatini, Maria D. C.
    Bulsara, Max K.
    Riera, Rachel
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (07):
  • [26] BUDGET IMPACT ANALYSIS OF BOTULINUM TOXIN A THERAPY FOR UPPER LIMB SPASTICITY IN THE UNITED KINGDOM
    Kurth, H.
    Remak, E.
    Hortobagyl, L.
    Desai, K.
    Abogunrin, S.
    Dinet, J.
    Gabriel, S.
    Bakheit, A. M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A620 - A620
  • [27] Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
    Abogunrin, Seye
    Hortobagyi, Linda
    Remak, Edit
    Dinet, Jerome
    Gabriel, Sylvie
    Bakheit, Abdel Magid O.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 185 - 193
  • [28] INCIDENCE OF CLOSTRIDIUM BOTULINUM TYPE E IN FISH PRODUCTS IN UNITED KINGDOM
    CANN, DC
    WILSON, BB
    SHEWAN, JM
    HOBBS, G
    [J]. NATURE, 1966, 211 (5045) : 205 - &
  • [29] Sixth nerve palsy following botulinum toxin injection for facial rejuvenation
    Bilge, Ayse Dolar
    Sadigov, Fariz
    Salar-Gomceli, Senem
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2017, 36 (02) : 193 - 194
  • [30] PRODUCTIVITY IN CANADA, THE UNITED KINGDOM, AND THE UNITED STATES
    Maddison, A.
    [J]. OXFORD ECONOMIC PAPERS-NEW SERIES, 1952, 4 (03): : 235 - 242